Abbott’s Libre 3 glucose monitor gets FDA clearance as CGM market intensifies

Dive Brief: Abbott has received 510(k) clearance from the Food and Drug Administration for FreeStyle Libre 3, the latest version of its continuous glucose monitor. The 14-day device is smaller and thinner than its predecessor, at about the size of two U.S. pennies stacked, and sends readings to a connected...

Dexcom says it’s not in acquisition talks

UPDATE: May 31, 2022:Dexcom said on Tuesday that it isn’t in “active discussions regarding a merger transaction at this time,” following a report that the company was looking to acquire Insulet. Bloomberg News, citing unidentified people familiar with the matter, reported last week that Dexcom, which makes continuous glucose monitors,...

Subscribe to

Our Newsletter!